Green Cross Health

Showing 2051 articles
Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

Business

Covenant Logistics Sees Freight Market Turning, But Margin Pressures Linger

Covenant Logistics Group struck a cautiously optimistic note in its Q4 2025 earnings call, citing improving freight fundamentals and rising bid activity, even as margin compression across key segments weighed on profits. The company is navigating the shift through fleet optimization, a reduced capex plan, and the integration of a new brokerage unit.